| 51 |
15030294 | AT1-receptor antagonism in hypertension: what has been learned with irbesartan? | 2003 May |
2 |
| 52 |
11855558 | Efficacy of irbesartan, a receptor selective antagonist of angiotensin II, in reducing portal hypertension. | 2002 Feb |
1 |
| 53 |
11901904 | [The best of 2001. Arterial hypertension]. | 2002 Jan |
1 |
| 54 |
11904530 | Pharmacodynamic studies on the angiotensin II type 1 antagonists irbesartan and candesartan based on angiotensin II dose response in humans. | 2002 Apr |
2 |
| 55 |
11910301 | Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial. | 2002 Apr |
2 |
| 56 |
11963637 | [Efficacy-safety relationship of AT1 angiotensin II receptor antagonists: current data]. | 2002 Jan-Feb |
1 |
| 57 |
11998539 | Results of a postal survey of the reasons for non-response by doctors in a Prescription Event Monitoring study of drug safety. | 2002 Mar |
1 |
| 58 |
12172412 | Cholestatic hepatitis related to use of irbesartan: a case report and a literature review of angiotensin II antagonist-associated hepatotoxicity. | 2002 Aug |
2 |
| 59 |
12184030 | [Irbesartan--antihypertensive treatment in patients with heart failure and diabetes mellitus]. | 2002 |
1 |
| 60 |
12378864 | [Role of angiotensin II antagonists in the treatment of hypertension]. | 2002 |
1 |
| 61 |
12452749 | Acute pancreatitis associated with angiotensin II receptor antagonists. | 2002 Dec |
1 |
| 62 |
12460701 | Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases. | 2002 Dec |
2 |
| 63 |
12851994 | Irbesartan-associated persistent edema of the eyelids, face, and neck. | 2002 Dec |
3 |
| 64 |
11300658 | Inhibition of the acute effects of angiotensin II by the receptor antagonist irbesartan in normotensive men. | 2001 Apr |
5 |
| 65 |
11465912 | Pharmacological differences among angiotensin II receptor antagonists. | 2001 |
3 |
| 66 |
11487548 | Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. | 2001 Aug |
3 |
| 67 |
11549097 | The pharmacokinetics and pharmacodynamics of irbesartan in heart failure. | 2001 Sep |
1 |
| 68 |
28095233 | Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries. | 2001 Mar |
1 |
| 69 |
28095239 | Evidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteries. | 2001 Mar |
1 |
| 70 |
10720881 | Blockade of angiotensin II type 1 receptors: effect on carotid and radial artery structure and function in hypertensive humans. | 2000 Jan-Feb |
1 |
| 71 |
10822210 | Irbesartan: review of pharmacology and comparative properties. | 2000 Spring |
1 |
| 72 |
10852648 | Irbesartan: an updated review of its use in cardiovascular disorders. | 2000 May |
2 |
| 73 |
10921256 | [The effect of angiotensin-II receptor antagonists on the vasoconstriction mechanisms in chronic heart failure]. | 2000 Apr-Jun |
1 |
| 74 |
10968237 | Preliminary experience with the angiotensin II receptor antagonist irbesartan in chronic kidney disease. | 2000 Aug |
3 |
| 75 |
11053475 | Opposing effects of angiotensin II on muscle and renal blood flow under euglycemic conditions. | 2000 Nov |
1 |
| 76 |
11206708 | Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors. | 2000 Nov-Dec |
1 |
| 77 |
11303957 | Inhibition of angiotensin II-induced inositol phosphate production by triacid nonpeptide antagonists in CHO cells expressing human AT1 receptors. | 2000 Dec |
1 |
| 78 |
15645839 | [Irbesartan in the treatment of arterial hypertension]. | 2000 Jun |
1 |
| 79 |
10193713 | Dose-related beneficial long-term hemodynamic and clinical efficacy of irbesartan in heart failure. | 1999 Apr |
1 |
| 80 |
10221067 | [Drug clinics. Drug of the month. Irbesartan (Aprovel)]. | 1999 Feb |
1 |
| 81 |
10541298 | The paradox of the low-renin state in diabetic nephropathy. | 1999 Nov |
2 |
| 82 |
10546920 | Time course and extent of angiotensin II antagonism after irbesartan, losartan, and valsartan in humans assessed by angiotensin II dose response and radioligand receptor assay. | 1999 Oct |
1 |
| 83 |
10684525 | Pharmacodynamics and Pharmacokinetics of Irbesartan in Patients With Mild to Moderate Hypertension. | 1999 Apr |
3 |
| 84 |
9475275 | Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects. | 1998 Feb |
2 |
| 85 |
9549663 | Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects. | 1998 Mar |
3 |
| 86 |
9607385 | Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension. | 1998 Apr |
1 |
| 87 |
9421695 | Irbesartan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in the management of hypertension. | 1997 Dec |
3 |
| 88 |
9438777 | Renoprotection and renin-angiotensin system blockade in diabetes mellitus. | 1997 Dec |
1 |
| 89 |
9449566 | High-performance liquid chromatographic assay for the quantitation of irbesartan (SR 47436/BMS-186295) in human plasma and urine. | 1997 Nov 21 |
1 |
| 90 |
9532514 | Rationale and pharmacology of angiotensin II receptor antagonists: current status and future issues. | 1997 Dec |
1 |
| 91 |
9532515 | Non-insulin-dependent diabetes mellitus, nephropathy, and the renin system. | 1997 Dec |
2 |
| 92 |
9532516 | Human pharmacokinetic/pharmacodynamic profile of irbesartan: a new potent angiotensin II receptor antagonist. | 1997 Dec |
2 |
| 93 |
8797143 | Dose-ranging study of the angiotensin II receptor antagonist irbesartan (SR 47436/BMS-186295) on blood pressure and neurohormonal effects in salt-deplete men. | 1996 Jul |
4 |
| 94 |
7611241 | Studies of the renal effects of angiotensin II receptor blockade: the confounding factor of acute water loading on the action of vasoactive systems. | 1995 Jul |
1 |
| 95 |
8149971 | Effect of SR 47436, a novel angiotensin II AT1 receptor antagonist, on human vascular smooth muscle cells in vitro. | 1994 Jan 14 |
2 |